PM to push ahead with limiting Green Pass to those who've received 3rd vaccine amid FDA recommendation to only give shot to Americans over 65 and at-risk groups
Horowitz says US panel received Israeli data 'unequivocally' showing extra shot is effective against Delta; Bennett op-ed: Waiting too long for booster would have squandered gains
Accumulating research suggests vaccine's superiority, possibly due to dosage level -- 100 micrograms against 30 -- or dosage interval, with Pfizer given 3 weeks apart and Moderna 4
US panel gives go-ahead of 3rd shot only to those over 65 or at high risk; officials concerned decision undermines efforts to make Green Pass available to those with booster shots
Experts overwhelmingly reject proposal to okay 3rd dose of Pfizer vaccine for anyone over 16, questioning whether data presented on Israel's booster campaign is applicable to US
As US officials set to mull okaying Pfizer's 3rd dose, data from a million Israelis shows it boosts protection from infection tenfold compared with eligible people who got 2 shots
Amid talk of 4th dose, serological study at Sheba hospital stokes optimism that booster shot may offer longer-lasting protection than previously thought
Recent comments